Phase II evaluation of phenesterin in patients with advanced ovarian cancer.
D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008875:Middle Aged; D009588:Nitrogen Mustard Compounds / Q000009:adverse effects / Q000627:therapeutic use*; D010051:Ovarian Neoplasms / Q000188:drug therapy*
D009588:Nitrogen Mustard Compounds; C100060:phenesterin